☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
NanOlogy Reports the Completion of Patient Enrollment of LSAM-PTX in P-IIa Trial for the Treatment of Nonoperable Lung Cancer
November 11, 2022
PharmaShots Weekly Snapshots (November 07-11 2022)
November 11, 2022
ImmunityBio Reports P-II/III (QUILT 3.032) Trial Results of N-803 + BCG for the Treatment of Bladder Cancer
November 11, 2022
Takeda’s Livtencity (maribavir) Receives the EC’s Marketing Authorization for the Treatment of Post-Transplant Cytomegalovirus Inf...
November 11, 2022
Parthenon Entered into a Multi-Year Non-Exclusive License and Supply Agreement with ImaginAb to Advance Anti-Cancer Therapies
November 11, 2022
Janssen Reports Post-Hoc Analysis of Tremfya (guselkumab) in P-III (DISCOVER-2) Study for Active Psoriatic Arthritis
November 11, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions